Friday, July 9, 2010

Oxis International, Inc. (OTCBB: OXIS)

Ever heard of OXIS International, Inc?



Oxis International, Inc. is a major nutraceutical to provide powerful antioxidants, namely Ergothioneine. Oxis International, Inc. was founded in 1966. Oxis International, Inc. for many years also focuses on the diagnosis while developing several patented and unique compounds have significant expertise in the field of oxidative stress including L-Ergothioneine ("ERGO"). Extensive and significant data have been obtained by researchers worldwide for the presence of L-Ergothioneine in human tissues. In addition to a powerful antioxidant, OXIS also has an extensive patent portfolio and a portfolio of therapeutic compounds.

Oxis International, Inc. engages in the research, development and sales of products that fight the harmful effects of "oxidative stress."

http://www.oxis.com
This site has covered all the necessary data to explain the contents of the products that will be discussed now. let's see a brief explanation below. a very interesting background for a company engaged in the treatment of oxidative stress.


INTELLECTUAL PROPERTY AND SCIENCE BACKGROUND
OXIS intellectual property for ERGO includes three patents and two pending patent applications and includes the synthesis of highly purified ERGO and ERGO a protective effect on mitochondria and structures are also important functions of the body. A number of scientific papers note Monograph mentioned in this web site indicates that the ERGO is one of various biological compounds with powerful antioxidant, anti-inflammatory, neuroprotective and other protection against oxidative stress intrinsic. ERGO react by itself, or react with other natural compounds to enhance the body's defense against oxidative stress intrinsic. So, OXIS focuses on developing performance products that deliver the benefits of ERGO taken manually in combination with other elements that can enhance various body armor systems.

Oxidative stress is a situation when the body's antioxidant and other defensive abilities to combat free radicals (highly reactive oxygen species alias and nitrogen) have been overwhelmed and the normal balance of healthy person has been lost or diminished. Therefore OXIS issued nutraceutical products such as therapeutic, cosmeceutical and formulation of clinical products developed internally and get permission for biotech companies and pharmaceuticals as drug candidates.

OXIS always focus on the natural protective substances because it is more possible to be safe and efficacious. OXIS main products are incorporating and emphasizing antioxidant "super multifaceted" compound, L-Ergothioneine ("ERGO"), as a key component. OXIS has several patents and pending applications relating to the ERGO is also relevant to business planning and cosmecuetical OXIS nutraceutical.

very interesting, isn’t it?


"ERGOTHIONEINE" SUPER ANTIOXIDANT FOR NUTRACEUTICAL, COSMECEUTICAL AND THERAPY

ERGO naturally made, water soluble, antioxidant amino acid produced by microbes in the soil multifaceted and most often found in (but not produce) different kinds of mushrooms, grape and meat. However, no commercially to extract the ERGO from natural sources and consuming enough food to provide for exploiting the potential ERGO health. Humans and animals usually have low levels of ERGO, since the number of ERGO in the diet is relatively small.

ERGO BENEFITS
Some of the benefits of the ERGO includes the ability to:
• Conserve and maintain the level of other antioxidants like vitamin E, vitamin C and glutathione;
• Increased respiration and oxidation of fat (probably contribute to increased energy and exercise capacity);
• Protect from damage to mitochondria (this is important because of potentially damaging reactive oxygen species produced when oxygen is usually metabolized in the mitochondria,
• Reducing the damaging effects of ultraviolet radiation environment (may be important in protecting the eyes against cataracts produce oxidative injury);
• Neutralize increased oxidative stress by providing the ROS (reactive oxygen species) and RNA (reactive nitrogen species) scavenging capacity, a property that protects the key molecules in the body, and,
• Protects against the impact of neurotoxins which is believed to have a casual role in the development and progress of cognitive decline.

Therapeutic Compounds
Therapeutic compounds and clinical products is an easy solution that can be used to treat disease. OXIS also has some therapeutic compounds present in order to be licensed, including some anti-inflammatory and antioxidant therapy with potential application in the treatment of neurodegenerative (Alzheimer's and Parkinson's), heart disease, diabetes and other conditions.

Treat oxidative stress
Oxidative stress caused by the unchecked activities of reactive oxygen species (ROS) and reactive nitrogen species (RNA). Both ROS and RNA is highly reactive, unstable molecules in healthy cells, are created and neutralized as part of normal cell life. However, if the production of free radicals and ROS / RNA exceeds our body's natural defense mechanism of oxidative damage on the vital molecule in our body can occur and can cause cell dysfunction, oxidative stress also cell death. This is also caused by inflammation, exposure to cigarette smoke, pollution, UV rays, radiation, certain drugs and other conditions. Oxidative stress also increases as we age.

FDA Approved CLINICAL PRODUCTS
Palosein (Orgotein) is an FDA approved drug OXIS for the treatment of arthritic inflammation in Veterinary use Palosein Called (NAD / Tone # 045-863). Palosein is Superoxide Dismutase (SOD) derived from beef liver. Currently, OXIS is in the recertification process manufacturing and actively seek partnerships with distributors to sell Palosein. OXIS will provide additional information on the progress Palosein like process that has been achieved.


MORE INFORMATION

If you feel curious, just try to open the link below and visit the official website of Oxis. Then, here they are:

0 Comments:

Post a Comment